• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期卵巢癌中17号染色体p13.3区域的等位基因缺失。

Allelic deletion on chromosome 17p13.3 in early ovarian cancer.

作者信息

Phillips N J, Ziegler M R, Radford D M, Fair K L, Steinbrueck T, Xynos F P, Donis-Keller H

机构信息

Department of Pathology, Saint Louis University School of Medicine, Missouri, USA.

出版信息

Cancer Res. 1996 Feb 1;56(3):606-11.

PMID:8564979
Abstract

Multiple chromosome 17 loci may be involved in ovarian carcinogenesis. Fifty-seven sporadic ovarian epithelial tumors were examined for loss of heterozygosity at 15 loci on chromosomes 17p. Eighty % (39 of 49) of informative tumors had allelic loss in 17p13.3 at D17S30, D17S28, or both loci within this region, including 3 of 7 tumors of low malignant potential and 4 of 5 nonmetastatic carcinomas. The smallest region of overlapping deletions extends from D17S28 to D17S30, a distance of 15 kb. Furthermore, several tumors have breakpoints within the region detected by the D17S30 probe. Chromosome 17p13.3 genes with potential tumor suppressor function include HIC-1, DPH2L (N. J. Phillips et al. Isolation of a human diphthamide biosynthesis gene on chromosome 17p13.3, submitted for publication)/OVCA1, PEDF, and CRK. The HIC-1 coding sequence lies i kb centromeric to the D17S28-S17S30 region of deletion (M. Makos Wales et al., Nat. Med., 1:570-577, 1995) but remains a candidate because 5'-regulatory elements may lie within the critical region. Portions of the DPH2L/OVCA1 coding sequence lie within the D17S28-D17S30 interval. Somatic cell hybrid analysis places PEDF in an interval including D17S28, D17S30, and D17S54, whereas CRK is excluded from this interval. Chromosome 17p13.3 loss precedes TP53 and BRCA1 region deletions because the latter changes are see only in high-stage carcinomas. Microsatellite instability plays only a minor role in sporadic ovarian carcinogenesis because only 1 of 57 tumors showed this finding.

摘要

多个17号染色体位点可能参与卵巢癌的发生。对57例散发性卵巢上皮性肿瘤进行了17号染色体短臂上15个位点杂合性缺失检测。80%(49例中有39例)的信息性肿瘤在17p13.3区域的D17S30、D17S28或这两个位点存在等位基因缺失,包括7例低恶性潜能肿瘤中的3例和5例非转移性癌中的4例。重叠缺失的最小区域从D17S28延伸至D17S30,距离为15kb。此外,一些肿瘤在D17S30探针检测到的区域内有断点。17号染色体短臂13.3区具有潜在肿瘤抑制功能的基因包括HIC-1、DPH2L(N.J.菲利普斯等人,人类二磷酸腺苷生物合成基因在17号染色体短臂13.3区的分离,待发表)/OVCA1、PEDF和CRK。HIC-1编码序列位于缺失的D17S28-S17S30区域着丝粒侧1kb处(M.马科斯·威尔士等人,《自然医学》,1:570-577,1995),但仍是一个候选基因,因为5'调控元件可能位于关键区域内。DPH2L/OVCA1编码序列的部分位于D17S28-D17S30区间内。体细胞杂交分析将PEDF定位在包括D17S28、D17S30和D17S54的区间内,而CRK被排除在该区间之外。17号染色体短臂13.3区的缺失先于TP53和BRCA1区域的缺失,因为后者的改变仅在晚期癌中出现。微卫星不稳定性在散发性卵巢癌发生中仅起次要作用,因为57例肿瘤中只有1例出现此现象。

相似文献

1
Allelic deletion on chromosome 17p13.3 in early ovarian cancer.早期卵巢癌中17号染色体p13.3区域的等位基因缺失。
Cancer Res. 1996 Feb 1;56(3):606-11.
2
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.散发性上皮性卵巢癌中位于BRCA1基因着丝粒侧的一个400 kb新型缺失单元。
Oncogene. 1996 Feb 15;12(4):735-40.
3
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.人类卵巢癌中6号染色体长臂、11号和17号染色体上杂合性的频繁缺失。
Cancer Res. 1990 May 1;50(9):2724-8.
4
Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Gynecol Oncol. 1998 Oct;71(1):77-82. doi: 10.1006/gyno.1998.5110.
5
Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.在恶性星形细胞瘤中,17号染色体上存在一个不同于p53的潜在第二肿瘤抑制基因参与其中的证据。
Cancer Res. 1992 Dec 1;52(23):6716-21.
6
Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.卵巢癌中17号染色体短臂杂合性缺失与p53突变之间的相关性较差。
Gynecol Oncol. 1996 Nov;63(2):173-9. doi: 10.1006/gyno.1996.0302.
7
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.上皮性卵巢肿瘤中位于家族性乳腺癌/卵巢癌基因座远端的17号染色体长臂上的一个缺失单元。
Cancer Res. 1993 Mar 15;53(6):1218-21.
8
Molecular genetic changes associated with ovarian cancer.与卵巢癌相关的分子遗传学改变。
Gynecol Oncol. 1994 Nov;55(2):245-52. doi: 10.1006/gyno.1994.1285.
9
[Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].[结直肠癌中人类17号染色体上p53基因区域的基因改变]
Genetika. 1998 Aug;34(8):1049-55.
10
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.在17p13.3上,位于TP53远端的一个基因作为无p53突变的乳腺肿瘤中等位基因缺失靶点的证据。
Cancer Res. 1994 Aug 1;54(15):4200-6.

引用本文的文献

1
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.基于基因表达谱荟萃分析鉴定上皮性卵巢癌中失调的长链非编码 RNA。
Int J Mol Sci. 2023 Jun 28;24(13):10798. doi: 10.3390/ijms241310798.
2
NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?纳米SBT-PEDF递送系统:对抗卵巢癌的一种有前景的方法?
Heliyon. 2023 Feb 12;9(2):e13676. doi: 10.1016/j.heliyon.2023.e13676. eCollection 2023 Feb.
3
Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages.
色素上皮衍生因子是一种抗血管内皮生长因子因子,通过减轻肿瘤相关巨噬细胞的极化来延缓卵巢癌的进展。
Cancer Gene Ther. 2022 Oct;29(10):1332-1341. doi: 10.1038/s41417-022-00447-4. Epub 2022 Mar 4.
4
Malignant ascites: a source of therapeutic protein against ovarian cancer?恶性腹水:一种抗卵巢癌治疗性蛋白质的来源?
Oncotarget. 2019 Oct 15;10(57):5894-5905. doi: 10.18632/oncotarget.27185.
5
The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway.肿瘤抑制因子OVCA1是一种通过泛素-蛋白酶体途径降解的半衰期较短的蛋白质。
Oncol Lett. 2019 Feb;17(2):2328-2334. doi: 10.3892/ol.2018.9852. Epub 2018 Dec 19.
6
Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer.延伸因子依赖性tRNA修饰途径在神经退行性疾病和癌症中的作用
Genes (Basel). 2018 Dec 28;10(1):19. doi: 10.3390/genes10010019.
7
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.一种经过改良的免疫毒素在卵巢癌的临床前研究中表现出良好的活性。
Sci Rep. 2017 Dec 22;7(1):18086. doi: 10.1038/s41598-017-17329-7.
8
OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.OVCA1在宫颈癌及上皮内瘤变中的表达及其与细胞周期蛋白D1和p16表达水平的相关性。
Oncol Lett. 2017 May;13(5):2929-2936. doi: 10.3892/ol.2017.5848. Epub 2017 Mar 13.
9
Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.色素上皮衍生因子(PEDF)的抗肿瘤作用:对癌症治疗的启示。一篇综述。
J Exp Clin Cancer Res. 2016 Jan 8;35:4. doi: 10.1186/s13046-015-0278-7.
10
Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy.色素上皮衍生因子:在雌激素依赖性组织中的临床意义及其在癌症治疗中的潜力。
Iran J Basic Med Sci. 2015 Sep;18(9):837-55.